Dave & Buster's Misses Earnings Estimates Amid Weak Comparable Sales
Dave & Buster’s Q1 2026 revenue and profit fell, missed forecasts, but management expects recovery and stronger cash flow ahead.
NOTRELOAD AI
Qualcomm in Talks to Acquire Jim Keller’s AI Chip Startup Tenstorrent
Qualcomm is in early talks to buy Jim Keller’s Tenstorrent to expand its AI chip capabilities and challenge Nvidia in data center and edge AI. Intel is also interested.
Adaptive Biotechnologies Plans to Split Its MRD and Immune Medicine Units
The company expects to decide the best path by year-end 2026.
Stride Plunges After Losing Major Texas Virtual School Contract
Stride shares plunged after Texas' Roscoe ISD decided not to renew its contract for Lone Star Online Academy, representing ~5% of 2025 enrollment. BMO highlights retention risks.
H.C. Wainwright Says CNTX Stock Drop Is 'Overdone' After CTIM-76 Ovarian Cancer Data
Context Therapeutics reported positive Phase 1 data for CTIM-76 in heavily pretreated platinum-resistant ovarian cancer, showing a 29% response rate and good safety, but the stock fell due to small trial size.
CMS Plans Permanent Medicare Drug Price Negotiations Starting 2029 – What It Means for Big Pharma
Medicare plans drug price cuts from 2029, hitting pharma stocks, but long-term impact may be limited by legal and market protections.